Fermented-milk bacteria: role in intestinal peristalsis regulation

Fermented-milk bacteria: role in intestinal peristalsis regulation

The aim of review. To demonstrate a role of fermented-milk bacteria, first of all Lactobacillus and Bifidumbacterium geni, and their metabolic products – short-chain fatty acids in regulation of peristalsis of the bowel.Original positions. In clinical studies the effect of probiotic strains on sever...

Full description

Saved in:

Bibliographic Details
Main Author:	Yu. O. Shulpekova
Format:	Article
Language:	Russian
Published:	Gastro LLC 2010-06-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	probiotics irritable bowel syndrome constipation
Online Access:	https://www.gastro-j.ru/jour/article/view/1527
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia
by: V. T. Ivashkin, et al.
Published: (2022-01-01)

Pathogenic role of intestinal microflora changes in patients with irritable bowel syndrome and treatment options
by: Ye. A. Poluektova, et al.
Published: (2014-09-01)

Discussion of the problem of functional constipation and irritable bowel syndrome in the reports of the International Congress on Neurogastroenterology and Motility (Bologna, 2012)
by: A. A. Sheptulin, et al.
Published: (2013-03-01)

Role of nutritional factors at the irritable bowel syndrome
by: Yu. O. Shulpekova, et al.
Published: (2015-10-01)

Bowel diseases and constipation in practice of the obstetrician and gynecologist
by: I. V. Kuznetsova, et al.
Published: (2015-03-01)

Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers
by: Yu. O. Shulpekova
Published: (2011-02-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Diagnosis of Functional Gastrointestinal Disorders and Choice of Treatment Regimen in Constipation Patients
by: I. V. Maev, et al.
Published: (2021-10-01)

Effect of combined therapy by pinaverium bromide and itopride hydrochloride on clinical semiology and quality of life of patients with combination of constipation variant of irritable bowel syndrome and functional dyspepsia
by: O. V. Krapivnaya, et al.
Published: (2015-05-01)

Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at diarrheal variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-05-01)

Comparative efficacy of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> composition and prucalopride in treatment of constipation variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-07-01)

Modern Possibilities of Using Lactulose in Clinical Practice
by: A. A. Sheptulin
Published: (2023-11-01)

Single Nucleotide Polymorphisms, Associated with Increased Risk of Irritable Bowel Syndrome with Predominant Constipation: A Meta Analysis
by: E. A. Trush, et al.
Published: (2024-08-01)

Continuously relapsing (for two years) course of diarrheal variant of IBS (<i>Clinical case</i>)
by: Ye. A. Poluektova, et al.
Published: (2013-10-01)

Pathogenetic Substantiation of the Therapeutic Impact on Microbiota in Irritable Bowel Syndrome
by: Yu. O. Shulpekova, et al.
Published: (2019-09-01)

Gastroesophageal reflux disease and the functional diseases of gastro-intestinal tract: are there any interrelations?
by: A. A. Sheptulin, et al.
Published: (2010-08-01)

Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease
by: K. V. Ivashkin, et al.
Published: (2021-04-01)

Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
by: O. V. Krapivnaya
Published: (2014-07-01)

Principles of Rational Nutrition for Managing Constipation
by: Yu. O. Shulpekova, et al.
Published: (2018-11-01)

Practical Recommendations of Scientific Society for the Study of Human Microbiome and Russian Gastroenterological Association (RGA) for Probiotics in Treatment and Prevention of Gastroenterological Diseases in Adults
by: V. T. Ivashkin, et al.
Published: (2020-05-01)

Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Irritable Bowel Syndrome who Have Suffered COVID-19
by: A. V. Nalyotov, et al.
Published: (2022-09-01)

Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases
by: A. A. Sheptulin
Published: (2022-01-01)

The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis
by: Ye. A. Poluektova, et al.
Published: (2013-03-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

What Do Gases in the Large Intestine Have to Do with Health?
by: Klaudia Pawełek, et al.
Published: (2025-02-01)

Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?
by: A. A. Sheptulin, et al.
Published: (2019-12-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Irritable Bowel Syndrome: What Are the Reasons for Dissatisfaction with the Treatment of Patients and Doctors? (Based on the Experience of Medical Institutions of the Northwestern Federal District of Russia)
by: A. Yu. Baranovsky, et al.
Published: (2024-01-01)

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?
by: Yu. A. Kucheryavy, et al.
Published: (2014-08-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms
by: Z. A. Mamieva, et al.
Published: (2022-01-01)

Irritable Bowel Syndrome Onset after New Coronavirus Infection COVID-19
by: I. Yu. Feklina, et al.
Published: (2022-03-01)

Small Intestinal Bacterial Overgrowth in Various Specialties of Medical Practice (Literature Review and Expert Council Resolution)
by: V. T. Ivashkin, et al.
Published: (2024-05-01)

The Role of Motility Impairment in the Pathogenesis of Functional Disorders of the Gastrointestinal Tract and Modern Possibilities for Their Treatment (Resolution of an Expert Council and Literature Review)
by: I. V. Maev, et al.
Published: (2020-01-01)

Functional Disorders of the Gastrointestinal Tract During the Pandemic of a New Coronavirus Infection
by: A. A. Sheptulin, et al.
Published: (2022-09-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

Experience in the Treatment of Irritable Bowel Syndrome Developed after a New Coronavirus Infection (COVID-19)
by: R. G. Myazin
Published: (2022-05-01)

COVID-19 Pandemic and IBS. Results of the All-Russian Observational Non-interventional Program to Study the Effectiveness of the Drug Kolofort® in Real Clinical Practice in Patients with Irritable Bowel Syndrome After a New Coronavirus Infection (VESNA)
by: V. T. Ivashkin, et al.
Published: (2023-12-01)

Intestinal Barrier, Permeability and Nonspecific Inflammation in Functional Gastrointestinal Disorders
by: A. L. Kovaleva, et al.
Published: (2020-09-01)

Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare
by: Yu. A. Kucheryavy, et al.
Published: (2015-12-01)